[go: up one dir, main page]

FI954990L - Aktiiviainetta sisältävä transdermaalinen valmiste - Google Patents

Aktiiviainetta sisältävä transdermaalinen valmiste Download PDF

Info

Publication number
FI954990L
FI954990L FI954990A FI954990A FI954990L FI 954990 L FI954990 L FI 954990L FI 954990 A FI954990 A FI 954990A FI 954990 A FI954990 A FI 954990A FI 954990 L FI954990 L FI 954990L
Authority
FI
Finland
Prior art keywords
active substance
preparation containing
transdermal preparation
transdermal
substance
Prior art date
Application number
FI954990A
Other languages
English (en)
Swedish (sv)
Other versions
FI954990A0 (fi
FI114444B (fi
Inventor
Wilfried Fischer
Thomas Struengmann
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of FI954990A0 publication Critical patent/FI954990A0/fi
Publication of FI954990L publication Critical patent/FI954990L/fi
Application granted granted Critical
Publication of FI114444B publication Critical patent/FI114444B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI954990A 1993-04-23 1995-10-19 Menetelmä aktiiviainetta sisältävän transdermaalisen valmisteen valmistamiseksi FI114444B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4313402A DE4313402A1 (de) 1993-04-23 1993-04-23 Transdermale Wirkstoffzubereitung
DE4313402 1993-04-23
PCT/EP1994/001259 WO1994025069A1 (de) 1993-04-23 1994-04-22 Transdermale wirkstoffzubereitung
EP9401259 1994-04-22

Publications (3)

Publication Number Publication Date
FI954990A0 FI954990A0 (fi) 1995-10-19
FI954990L true FI954990L (fi) 1995-11-23
FI114444B FI114444B (fi) 2004-10-29

Family

ID=6486248

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954990A FI114444B (fi) 1993-04-23 1995-10-19 Menetelmä aktiiviainetta sisältävän transdermaalisen valmisteen valmistamiseksi

Country Status (13)

Country Link
US (1) US5738869A (fi)
EP (1) EP0695193B1 (fi)
JP (1) JP4334613B2 (fi)
AT (1) ATE176593T1 (fi)
AU (1) AU6721094A (fi)
DE (2) DE4313402A1 (fi)
DK (1) DK0695193T3 (fi)
ES (1) ES2130420T3 (fi)
FI (1) FI114444B (fi)
GR (1) GR3029963T3 (fi)
NO (1) NO311919B1 (fi)
WO (1) WO1994025069A1 (fi)
ZA (1) ZA942848B (fi)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
US6623752B1 (en) * 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid
DE19641259A1 (de) * 1996-10-07 1998-04-16 Kade Pharma Fab Gmbh Arzneimittel auf Basis von Diclofenac
CN1072482C (zh) * 1996-11-08 2001-10-10 山东医科大学 低分子肝素脂质体喷胶剂及制备工艺
US20010003580A1 (en) * 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE19945522A1 (de) * 1999-09-23 2001-04-05 Hexal Ag Pharmazeutisches, wirkstoffhaltiges Gel
BR0001144B1 (pt) * 2000-02-21 2013-10-22 Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10137082A1 (de) * 2001-07-28 2003-02-13 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
US20040224010A1 (en) * 2002-11-15 2004-11-11 Optime Therapeutics, Inc. Ophthalmic liposome compositions and uses thereof
ATE385779T1 (de) * 2002-12-20 2008-03-15 Idexx Lab Inc Dicolfenac-haltige liposomale schmerzstillende formulierung und ihre verwendung zur behandlung von pferden
US6936273B2 (en) * 2002-12-20 2005-08-30 Idexx Laboratories, Inc. Liposomal analgesic formulation and use
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8795703B2 (en) 2004-09-28 2014-08-05 Atrium Medical Corporation Stand-alone film and methods for making the same
EP1863435B1 (en) * 2005-03-31 2016-11-02 Unilever PLC Enhanced delivery of skin benefit agents
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
AU2007311019B2 (en) 2006-10-17 2013-05-16 Nuvo Pharmaceuticals, Inc Diclofenac gel
JP5371235B2 (ja) * 2006-12-06 2013-12-18 ロート製薬株式会社 皮膚外用剤
WO2009101412A1 (en) * 2008-02-13 2009-08-20 Cipla Limited Topical pharmaceutical composition
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
PL2387391T3 (pl) * 2009-07-24 2017-09-29 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Sposób otrzymywania ciekłej kompozycji stosowalnej w postaci piany na skórę oraz kompozycja do aplikowania miejscowego
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
EP2593141B1 (en) 2010-07-16 2018-07-04 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
US20130309215A1 (en) * 2012-05-15 2013-11-21 Mika Pharma Gesellschaft Fur Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmaceutical composition
DE102013004199A1 (de) * 2012-05-15 2013-11-21 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmazeutische Zusammensetzung
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
JP6449554B2 (ja) * 2014-03-30 2019-01-09 小林製薬株式会社 外用医薬組成物
EA201791437A1 (ru) 2014-12-31 2017-12-29 Лантеус Медикал Имэджинг, Инк. Композиции микросфер c инкапсулированным в липиде газом и соответствующие способы
JP6542006B2 (ja) * 2015-03-31 2019-07-10 小林製薬株式会社 外用医薬組成物
EP3452108A4 (en) 2016-05-04 2019-12-25 Lantheus Medical Imaging, Inc. METHOD AND DEVICES FOR THE PRODUCTION OF ULTRASONIC CONTRASTING AGENTS
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents
CN109862885A (zh) * 2016-10-18 2019-06-07 Lts勒曼治疗系统股份公司 双层局部治疗系统
US20250099369A1 (en) 2023-09-27 2025-03-27 Andros Pharmaceuticals Co., Ltd. Topical delivery compositions comprising non-steroidal anti-inflammatory drugs

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2374910A1 (fr) * 1976-10-23 1978-07-21 Choay Sa Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations
US4439432A (en) * 1982-03-22 1984-03-27 Peat Raymond F Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
DE3402928A1 (de) * 1984-01-28 1985-08-08 Roshdy Dipl.-Chem. Dr. 5000 Köln Ismail Mittel zur behandlung von herzerkrankungen
EP0151989B1 (de) * 1984-01-28 1991-04-10 Roshdy Dr. Ismail Mittel zur Behandlung von Herzerkrankungen
US4612194A (en) * 1984-02-15 1986-09-16 Roshdy Ismail Anti-rheumatic agents and their use
DE3507791A1 (de) * 1984-03-07 1985-09-26 Roshdy Ismail Mittel zum schutz der haut
DE3586859D1 (de) * 1984-03-07 1993-01-07 Roshdy Ismail Mittel zur behandlung und zum schutz der haut.
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
DE3506881A1 (de) * 1985-02-27 1986-08-28 RODISMA pharmazeutische Produkte GmbH, 5000 Köln Vitamin e spray
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
US4745105A (en) * 1986-08-20 1988-05-17 Griffin Charles C Low molecular weight heparin derivatives with improved permeability
US4745107A (en) * 1986-08-20 1988-05-17 Foley Kevin M Heparin derivatives with improved permeability
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
IT1229489B (it) * 1988-12-09 1991-09-03 Altergon Sa Composizioni farmaceutiche lipidiche per uso topico atte a veicolare un principio attivo antiinfiammatorio idrosolubile
DE3904674A1 (de) * 1989-02-16 1990-08-23 Cassella Ag Verwendung einer wirkstoffkombination zur behandlung rheumatischer erkrankungen
DE3908047A1 (de) * 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh Hochdisperse pharmazeutische zusammensetzung
AU664178B2 (en) * 1991-03-19 1995-11-09 Vithal J. Rajadhyaksha Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
US5498420A (en) * 1991-04-12 1996-03-12 Merz & Co. Gmbh & Co. Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions

Also Published As

Publication number Publication date
NO954215L (no) 1995-12-14
DE59407810D1 (de) 1999-03-25
WO1994025069A1 (de) 1994-11-10
AU6721094A (en) 1994-11-21
DE4313402A1 (de) 1994-10-27
JP4334613B2 (ja) 2009-09-30
FI954990A0 (fi) 1995-10-19
ZA942848B (en) 1995-10-25
US5738869A (en) 1998-04-14
DK0695193T3 (da) 1999-09-20
ATE176593T1 (de) 1999-02-15
FI114444B (fi) 2004-10-29
NO954215D0 (no) 1995-10-20
JPH08509715A (ja) 1996-10-15
EP0695193B1 (de) 1999-02-10
GR3029963T3 (en) 1999-07-30
ES2130420T3 (es) 1999-07-01
NO311919B1 (no) 2002-02-18
EP0695193A1 (de) 1996-02-07

Similar Documents

Publication Publication Date Title
FI954990L (fi) Aktiiviainetta sisältävä transdermaalinen valmiste
FI933001L (fi) Antigastrit-aemne
FI956113A0 (fi) Fungisidisia vaikuttavien aineiden yhdistelmiä
FI960156A7 (fi) Bentsyylioksikinuklidiinit aineet P antagonisteina
DE69014498D1 (de) Hyposensibilisierende wirksame Substanz.
FI895681A0 (fi) Farmaceutisk komposition foer systemisk transdermal tillfoersel.
FI962555A0 (fi) Kasvittumisenestoaine
FI950774L (fi) Valmiste käytettäväksi 3-ketodesogestreeliä sisältävään transdermaaliseen applikaatioon
ES2018451A4 (es) Material microencapsulado agricolamente activo
FI961630A7 (fi) Terapeuttisia aineita
NO924929D0 (no) Farmasoeytisk aktive benzoquinazolinforbindelser
NO973471D0 (no) Transdermal formulering
BR9607722A (pt) Formulação transdérmica
FI962550A7 (fi) Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoitukses sa
FI896091A0 (fi) Korkeatoimiset polarisaattorit
TR24383A (tr) Konsantre yuezey aktif madde granuelleri yapmaya mahsus yoentem
FI946128A7 (fi) Biologisesti aktiiviset yhdisteet
DE69430362D1 (de) Ektoparasitizide formulierung
NO910022D0 (no) Fungiside virkestoffkombinasjoner.
FI97854B (fi) Fungisidisia vaikuttavien aineiden yhdistelmiä
BR9301172A (pt) Aerossois dosadores contendo a substancia ativa flezelastina e estruturas afins
FI955896L (fi) Uudet aktiiviset yhdisteet
FI911554A7 (fi) Kemiallisia formulaatioita
FI932786L (fi) Vaikuttavaa ainetta luovuttava laite
DE59309194D1 (de) Aktive clamping-schaltung

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 114444

Country of ref document: FI

MM Patent lapsed